Abstract:Objective. Fetal growth restriction (FGR) is a significant contributor to negative pregnancy and postnatal developmental outcomes. Currently, the exact pathological mechanism of FGR remains unknown. This study aims to utilize multiomics sequencing technology to investigate potential relationships among mRNA, gut microbiota, and metabolism in order to establish a theoretical foundation for diagnosing and understanding the molecular mechanisms underlying FGR. Methods. In this study, 11 healthy pregnant women and nine pregnant women with FGR were divided into Control group and FGR group based on the health status. Umbilical cord blood, maternal serum, feces, and placental tissue samples were collected during delivery. RNA sequencing, 16S rRNA sequencing, and metabolomics methods were applied to analyze changes in umbilical cord blood circulating mRNA, fecal microbiota, and metabolites. RT-qPCR, ELISA, or western blot were used to detect the expression of top 5 differential circulating mRNA in neonatal cord blood, maternal serum, or placental tissue samples. Correlation between differential circulating mRNA, microbiota, and metabolites was analyzed by the Spearman coefficient. Results. The top 5 mRNA genes in FGR were altered with the downregulation of TRIM34, DEFA3, DEFA1B, DEFA1, and QPC, and the upregulation of CHPT1, SMOX, FAM83A, GDF15, and NAPG in newborn umbilical cord blood, maternal serum, and placental tissue. The abundance of Bacteroides, Akkermansia, Eubacterium_coprostanoligenes_group, Phascolarctobacterium, Parasutterella, Odoribacter, Lachnospiraceae_UCG_010, and Dielma were significantly enriched in the FGR group. Metabolites such as aspartic acid, methionine, alanine, L-tryptophan, 3-methyl-2-oxovalerate, and ketoleucine showed notable functional alterations. Spearman correlation analysis indicated that metabolites like methionine and alanine, microbiota (Tyzzerella), and circulating mRNA (TRIM34, SMOX, FAM83A, NAPG) might play a role as mediators in the communication between the gut and circulatory system interaction in FGR. Conclusion. Metabolites (METHIONINE, alanine) as well as microbiota (Tyzzerella) and circulating mRNA (TRIM34, SMOX, FAM83A, NAPG) were possible mediators that communicated the interaction between the gut and circulatory systems in FGR.

Alterations in the Gut Microbiome and Metabolisms in Pregnancies with Fetal Growth Restriction

The Role of Microbiomes in Pregnant Women and Offspring: Research Progress of Recent Years

Potential Association of Gut Microbial Metabolism and Circulating mRNA Based on Multiomics Sequencing Analysis in Fetal Growth Restriction

The fecal microbiota of gravidas with fetal growth restriction newborns characterized by metagenomic sequencing

Characteristics of the gut microbiota in pregnant women with fetal growth restriction

The Effects of Gut Microbiota on Metabolic Outcomes in Pregnant Women and Their Offspring

Dynamic alteration in the gut microbiota and metabolome during the pregnancy

Calorie restriction during gestation impacts maternal and offspring fecal microbiome in mice

Metabolic and fecal microbial changes in adult fetal growth restricted mice

Gut Microbiota, Inflammation, and Probiotic Supplementation in Fetal Growth Restriction—A Comprehensive Review of Human and Animal Studies

Metabolomic profiling of human feces and plasma from extrauterine growth restriction infants

Dynamics of the Gut Microbiota and Faecal and Serum Metabolomes during Pregnancy—A Longitudinal Study

Landscape of the gut mycobiome dynamics during pregnancy and its relationship with host metabolism and pregnancy health

Gut microbial network signatures of early colonizers in preterm neonates with extrauterine growth restriction

Maternal gut microbiota in the health of mothers and offspring: from the perspective of immunology

The Impact of Gut Microbiome on Metabolic Disorders During Catch-Up Growth in Small-for-Gestational-Age

Intestinal flora and pregnancy complications: Current insights and future prospects

The interplay between the gut microbiota and metabolism during the third trimester of pregnancy

Intergenerational association of gut microbiota and metabolism with perinatal folate metabolism and neural tube defects

The maternal microbiome promotes placental development in mice

Alterations of gut microbiota in gestational diabetes patients during the second trimester of pregnancy in the Shanghai Han population